oaktree specialty lending corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies. the fund seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. it invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and ebitda between $3 million and $50 million. the fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. it primarily invests in north america. the fund seeks to be a lead investor in its p
Company profile
Ticker
OCSL
Exchange
Website
CEO
Armen Panossian
Employees
Incorporated
Location
Fiscal year end
Former names
Fifth Street Finance Corp, Fifth Street Finance Corp.
SEC CIK
Corporate docs
IRS number
261219283
OCSL stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
5 Mar 24
8-K
Oaktree Specialty Lending Corporation Announces First Fiscal Quarter 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share
1 Feb 24
10-Q
2024 Q1
Quarterly report
1 Feb 24
DEFA14A
Additional proxy soliciting materials
30 Jan 24
DEF 14A
Definitive proxy
22 Jan 24
DEFA14A
Additional proxy soliciting materials
19 Jan 24
DEFA14A
Additional proxy soliciting materials
10 Jan 24
DEF 14A
Definitive proxy
10 Jan 24
PRE 14A
Preliminary proxy
21 Dec 23
8-K
Oaktree Specialty Lending Corporation Announces Fourth Fiscal Quarter and Full Year 2023
14 Nov 23
Transcripts
OCSL
Earnings call transcript
2024 Q1
1 Feb 24
OCSL
Earnings call transcript
2023 Q4
14 Nov 23
OCSL
Earnings call transcript
2023 Q3
3 Aug 23
OCSL
Earnings call transcript
2023 Q3
3 Aug 23
OCSL
Earnings call transcript
2023 Q2
4 May 23
OCSL
Earnings call transcript
2023 Q1
7 Feb 23
OCSL
Earnings call transcript
2022 Q4
15 Nov 22
OCSL
Earnings call transcript
2022 Q3
4 Aug 22
OCSL
Earnings call transcript
2022 Q2
5 May 22
OCSL
Earnings call transcript
2022 Q1
3 Feb 22
Latest ownership filings
4
PHYLLIS R CALDWELL
14 Feb 24
4
IMPEL PHARMACEUTICALS INC
4 Dec 23
3
IMPEL PHARMACEUTICALS INC
20 Nov 23
SC 13D/A
OAKTREE CAPITAL MANAGEMENT LP
7 Aug 23
SC 13D/A
OAKTREE CAPITAL MANAGEMENT LP
1 Aug 23
4
Ashley Pak
12 Apr 23
4
Matthew Stewart
27 Mar 23
4
Christopher McKown
20 Mar 23
4
PHYLLIS R CALDWELL
20 Mar 23
4
Mathew Pendo
13 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Dec 22 | Sep 22 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 145.54 mm | 145.54 mm | 145.54 mm | 145.54 mm | 145.54 mm | 145.54 mm |
Cash burn (monthly) | (no burn) | (no burn) | 258.33 k | (no burn) | 636.33 k | 9.08 mm |
Cash used (since last report) | n/a | n/a | 1.55 mm | n/a | 3.81 mm | 54.35 mm |
Cash remaining | n/a | n/a | 143.99 mm | n/a | 141.73 mm | 91.19 mm |
Runway (months of cash) | n/a | n/a | 557.4 | n/a | 222.7 | 10.0 |
Institutional ownership, Q3 2023
54.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 186 |
Opened positions | 26 |
Closed positions | 15 |
Increased positions | 71 |
Reduced positions | 52 |
13F shares | Current |
---|---|
Total value | 565.00 bn |
Total shares | 42.61 mm |
Total puts | 14.50 k |
Total calls | 123.60 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Springhouse Capital | 7.27 mm | $30.75 mm |
Tannenbaum Leonard M | 7.03 mm | $37.40 mm |
Oaktree Capital Management | 1.85 mm | $37.27 bn |
Bruni J V & Co | 1.53 mm | $30.71 bn |
MS Morgan Stanley | 1.49 mm | $29.91 bn |
Van Eck Associates | 1.28 mm | $25.62 bn |
LSV Asset Management | 1.14 mm | $22.81 bn |
CLARET ASSET MANAGEMENT | 1.13 mm | $22.72 bn |
Ares Management | 1.08 mm | $21.69 bn |
Lindbrook Capital | 951.56 k | $19.15 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Nov 23 | Oaktree-TCDRS Strategic Credit | Warrants Common Stock | Other | Acquire J | Yes | No | 0.01 | 445,294 | 4.45 k | 3,117,057 |
23 Mar 23 | Matthew Stewart | Common Stock, par value $0.01 per share | Buy | Acquire P | No | No | 18 | 500 | 9.00 k | 9,668 |
17 Mar 23 | Christopher McKown | Common Stock, par value $0.01 per share | Buy | Acquire P | No | No | 17.7884 | 1,000 | 17.79 k | 5,092 |
17 Mar 23 | Phyllis R Caldwell | Common Stock, par value $0.01 per share | Buy | Acquire P | No | No | 17.72 | 500 | 8.86 k | 9,166 |
16 Mar 23 | Phyllis R Caldwell | Common Stock, par value $0.01 per share | Buy | Acquire P | No | No | 18.1899 | 500 | 9.09 k | 8,666 |
16 Mar 23 | Phyllis R Caldwell | Common Stock, par value $0.01 per share | Buy | Acquire P | No | No | 18.185 | 500 | 9.09 k | 8,166 |
News
JMP Securities Reiterates Market Outperform on Oaktree Specialty Lending, Maintains $21 Price Target
26 Mar 24
Wells Fargo Maintains Overweight on Oaktree Specialty Lending, Lowers Price Target to $20.5
2 Feb 24
Keefe, Bruyette & Woods Downgrades Oaktree Specialty Lending to Market Perform
2 Feb 24
Oaktree Specialty Lending Q1 Adj EPS $0.57 Misses $0.61 Estimate, Sales $97.98M Miss $100.47M Estimate
1 Feb 24
Earnings Scheduled For February 1, 2024
1 Feb 24
Press releases
Oaktree Specialty Lending Corporation Announces Tax Character of Distributions for Calendar Year 2023
14 Feb 24
Oaktree Specialty Lending Corporation Announces First Fiscal Quarter 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share
1 Feb 24
Oaktree Specialty Lending Corporation Schedules First Fiscal Quarter Earnings Conference Call for February 1, 2024
3 Jan 24